Biora Therapeutics, Inc. Form D Notices of Exempt Offering of Securities
Notices filed with the SEC for securities sold without registration under Regulation D or Section 4(a)(5), newest first. Values are as filed.
- 2020-04-27: Federal exemption Rule 506(b); Types of securities offered Equity; OptionToAcquire; SecurityToBeAcquired; Date of first sale 2020-04-03; Total offering amount $59,999,998.
- 2020-04-20: Federal exemption Rule 506(b); Types of securities offered Equity; OptionToAcquire; SecurityToBeAcquired; Date of first sale 2020-04-03; Total offering amount $59,999,998.
- 2019-11-27: Federal exemption Rule 506(b); Types of securities offered Equity; OptionToAcquire; SecurityToBeAcquired; Date of first sale 2019-11-12; Total offering amount $105,502,086.
- 2019-09-13: Federal exemption Rule 506(b); Types of securities offered Equity; OptionToAcquire; SecurityToBeAcquired; Date of first sale 2019-08-27; Total offering amount $100,000,000.
| Filed | Federal exemption | Types of securities offered | Date of first sale | Total offering amount | Total amount sold | Total remaining to be sold | Investors who have already invested |
|---|---|---|---|---|---|---|---|
| 2020-04-27 D/A | Rule 506(b) | Equity; OptionToAcquire; SecurityToBeAcquired | 2020-04-03 | $59,999,998 | $9,999,999 | $49,999,999 | 1 |
| 2020-04-20 | Rule 506(b) | Equity; OptionToAcquire; SecurityToBeAcquired | 2020-04-03 | $59,999,998 | $9,999,999 | $49,999,999 | 1 |
| 2019-11-27 | Rule 506(b) | Equity; OptionToAcquire; SecurityToBeAcquired | 2019-11-12 | $105,502,086 | $31,124,999 | $74,377,087 | 3 |
| 2019-09-13 | Rule 506(b) | Equity; OptionToAcquire; SecurityToBeAcquired | 2019-08-27 | $100,000,000 | $25,000,002 | $74,999,998 | 1 |
| 2017-11-09 | Rule 506(b) | Equity; OptionToAcquire; SecurityToBeAcquired | 2017-10-27 | $55,000,001 | $50,000,000 | $5,000,001 | 1 |
| 2015-06-17 | Rule 506(b) | Equity; OptionToAcquire; SecurityToBeAcquired | 2015-06-08 | Indefinite | $0 | Indefinite | 3 |